Skip to main content
Top
Published in: International Journal of Clinical Oncology 4/2011

01-08-2011 | Original Article

Retrospective analysis of prognostic outcome of gastric cancer in young patients

Authors: Rieko Nakamura, Yoshiro Saikawa, Tsunehiro Takahashi, Hiroya Takeuchi, Humiki Asanuma, Yoshinori Yamada, Yuko Kitagawa

Published in: International Journal of Clinical Oncology | Issue 4/2011

Login to get access

Abstract

Background

It has been suggested that gastric cancer in young patients has a worse prognosis than in older patients, but this is controversial. This retrospective investigation was undertaken to understand the clinicopathological features and identify the prognostic factors of gastric cancer in young patients.

Methods

Patients included in this study were those treated and followed up for gastric cancer from 1989 to 2005. Operative records, clinical, pathological, and follow-up data were reviewed. The critical age cut-off value for obtaining distinctive prognoses was 34 years.

Results

Of 1730 gastric cancer patients whose records were reviewed, 27 were less than 34 years old (YGC group). The YGC group contained significantly higher percentages of females, stage IV, macroscopic type 4 tumors, poorly differentiated histology, peritoneal dissemination, and epigastric pain symptoms than the gastric cancer group aged 34 years or more (OGC group). Survival in the YGC group was significantly worse than in the OGC group (p = 0.0363). Ten-year survival was 68.5% in the YGC group and 81.8% in the OGC group. Survival in the YGC group was poorer for the stage IV patients, compared with OGC patients, especially for the stage IV patients with peritoneal dissemination and without liver metastases (H0P1 patients) (p = 0.049).

Conclusions

Age in gastric cancer affects the prognosis, which in gastric cancer patients less than 34 years old was significantly poorer than for older patients, because of the high incidence of stage IV cancer with peritoneal dissemination in gastric cancer patients less than 34 years old.
Literature
1.
go back to reference Mitsudomi T, Matsusaka T, Wakasugi K et al (1989) A clinicopathological study of gastric cancer with special reference to age of the patients: an analysis of 1630 cases. World J Surg 13:225–230PubMedCrossRef Mitsudomi T, Matsusaka T, Wakasugi K et al (1989) A clinicopathological study of gastric cancer with special reference to age of the patients: an analysis of 1630 cases. World J Surg 13:225–230PubMedCrossRef
2.
go back to reference Fujimoto S, Takahashi M, Ohkubo H et al (1994) Comparative clinicopathological features of early gastric cancer in young and older patients. Surgery 115:516–520PubMed Fujimoto S, Takahashi M, Ohkubo H et al (1994) Comparative clinicopathological features of early gastric cancer in young and older patients. Surgery 115:516–520PubMed
3.
go back to reference Eguchi T, Takahashi Y, Yamagata M et al (1999) Gastric cancer in young patients. J Am Coll Surg 188:22–26PubMedCrossRef Eguchi T, Takahashi Y, Yamagata M et al (1999) Gastric cancer in young patients. J Am Coll Surg 188:22–26PubMedCrossRef
4.
go back to reference Matley PJ, Dent DM, Madden MV et al (1988) Gastric carcinoma in young adults. Ann Surg 208:593–596PubMedCrossRef Matley PJ, Dent DM, Madden MV et al (1988) Gastric carcinoma in young adults. Ann Surg 208:593–596PubMedCrossRef
5.
6.
7.
go back to reference Holburt E, Freedman SI (1987) Gastric carcinoma in patients younger than 36 years. Cancer 60:1395–1399PubMedCrossRef Holburt E, Freedman SI (1987) Gastric carcinoma in patients younger than 36 years. Cancer 60:1395–1399PubMedCrossRef
8.
go back to reference Bloss RS, Miller TA, Copeland EM (1980) Carcinoma of the stomach in the young adult. Surg Gynecol Obstet 150:883–886PubMed Bloss RS, Miller TA, Copeland EM (1980) Carcinoma of the stomach in the young adult. Surg Gynecol Obstet 150:883–886PubMed
9.
go back to reference Lai IR, Lee WJ, Chen CN et al (1997) Gastric cancer in the young. Hepatogastrectomy 44:1641–1645 Lai IR, Lee WJ, Chen CN et al (1997) Gastric cancer in the young. Hepatogastrectomy 44:1641–1645
10.
go back to reference Medina-Franco H, Melsin MJ, Cortes-Gonzales R (2000) Clinicopathological characteristics of gastric carcinoma in young and elderly patients: a comparative study. Ann Surg Oncol 7:515–519PubMedCrossRef Medina-Franco H, Melsin MJ, Cortes-Gonzales R (2000) Clinicopathological characteristics of gastric carcinoma in young and elderly patients: a comparative study. Ann Surg Oncol 7:515–519PubMedCrossRef
11.
go back to reference Kokkola A, Sipponen P (2000) Gastric carcinoma in young adults. Hepatogastroenterology 48:1552–1555 Kokkola A, Sipponen P (2000) Gastric carcinoma in young adults. Hepatogastroenterology 48:1552–1555
12.
go back to reference Koea JB, Karpeh MS, Brennan MF (2000) Gastric cancer in young patients: demographic, clinicopathological and prognostic factors in 92 patients. Ann Surg Oncol 7:346–351PubMedCrossRef Koea JB, Karpeh MS, Brennan MF (2000) Gastric cancer in young patients: demographic, clinicopathological and prognostic factors in 92 patients. Ann Surg Oncol 7:346–351PubMedCrossRef
13.
go back to reference Kim DY, Ryu SY, Kim YJ et al (2003) Clinicopathological characteristics of gastric carcinoma in young patients. Langenbecks Arch Surg 388:245–249PubMedCrossRef Kim DY, Ryu SY, Kim YJ et al (2003) Clinicopathological characteristics of gastric carcinoma in young patients. Langenbecks Arch Surg 388:245–249PubMedCrossRef
14.
go back to reference Santoro R, Carboni P, Lepiane P et al (2007) Clinicopathological features and prognosis of gastric cancer in European adults. Br J Surg 94:737–742PubMedCrossRef Santoro R, Carboni P, Lepiane P et al (2007) Clinicopathological features and prognosis of gastric cancer in European adults. Br J Surg 94:737–742PubMedCrossRef
15.
go back to reference Llanos O, Butte JM, Crovari F et al (2006) Survival of young patients after gastrectomy for gastric cancer. World J Surg 30:17–20PubMedCrossRef Llanos O, Butte JM, Crovari F et al (2006) Survival of young patients after gastrectomy for gastric cancer. World J Surg 30:17–20PubMedCrossRef
16.
go back to reference Lauren P (1965) The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. Acta Pathol Microbiol Scand 64:31–49PubMed Lauren P (1965) The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. Acta Pathol Microbiol Scand 64:31–49PubMed
17.
go back to reference Antonioli DA, Goldman H (1982) Changes in the location and the type of gastric adenocarcinoma. Cancer 50:775–781PubMedCrossRef Antonioli DA, Goldman H (1982) Changes in the location and the type of gastric adenocarcinoma. Cancer 50:775–781PubMedCrossRef
18.
go back to reference Sipponen P, Jarvi O, Kekki M et al (1987) Decreased incidence of intestinal and diffuse types of gastric carcinoma in Finland during 20-years period. Scand J Gastroenterol 22:865–871PubMedCrossRef Sipponen P, Jarvi O, Kekki M et al (1987) Decreased incidence of intestinal and diffuse types of gastric carcinoma in Finland during 20-years period. Scand J Gastroenterol 22:865–871PubMedCrossRef
19.
go back to reference Ramos-De la Medina A, Salgado-Nesme N et al (2004) Clinicopathologic characteristics of gastric cancer in a young patient population. J Gastrointest Surg 8(3):240–244PubMedCrossRef Ramos-De la Medina A, Salgado-Nesme N et al (2004) Clinicopathologic characteristics of gastric cancer in a young patient population. J Gastrointest Surg 8(3):240–244PubMedCrossRef
20.
go back to reference Koea JB, Karpeh MS, Brennan MF (2000) Gastric cancer in young patients: demographic, clinicopathological, and prognostic factors in 92 patients. Ann Surg Oncol 7(5):346–351PubMedCrossRef Koea JB, Karpeh MS, Brennan MF (2000) Gastric cancer in young patients: demographic, clinicopathological, and prognostic factors in 92 patients. Ann Surg Oncol 7(5):346–351PubMedCrossRef
21.
go back to reference Nakamura T, Yao T, Niho Y et al (1999) A clinicopathological study in young patients with gastric carcinoma. J Surg Oncol 71(4):214–219PubMedCrossRef Nakamura T, Yao T, Niho Y et al (1999) A clinicopathological study in young patients with gastric carcinoma. J Surg Oncol 71(4):214–219PubMedCrossRef
22.
go back to reference Lo SS, Kuo HS, Wu CW et al (1999) Poorer prognosis in young patients with gastric cancer? Hepatogastroenterology 46(28):2690–2693PubMed Lo SS, Kuo HS, Wu CW et al (1999) Poorer prognosis in young patients with gastric cancer? Hepatogastroenterology 46(28):2690–2693PubMed
23.
go back to reference Wu MS, Chen CJ, Lin JT (2005) Host-environment interactions: their impact on progression from gastric inflammation to carcinogenesis and on development of new approaches to prevent and treat gastric cancer. Cancer Epidemiol Biomarkers Prev 14:1878–1882 (review)PubMedCrossRef Wu MS, Chen CJ, Lin JT (2005) Host-environment interactions: their impact on progression from gastric inflammation to carcinogenesis and on development of new approaches to prevent and treat gastric cancer. Cancer Epidemiol Biomarkers Prev 14:1878–1882 (review)PubMedCrossRef
24.
go back to reference Oliveira C, Seruca R, Carneiro F (2006) Genetics, pathology, and clinics of familial gastric cancer. Int J Surg Pathol 14:21–33PubMedCrossRef Oliveira C, Seruca R, Carneiro F (2006) Genetics, pathology, and clinics of familial gastric cancer. Int J Surg Pathol 14:21–33PubMedCrossRef
Metadata
Title
Retrospective analysis of prognostic outcome of gastric cancer in young patients
Authors
Rieko Nakamura
Yoshiro Saikawa
Tsunehiro Takahashi
Hiroya Takeuchi
Humiki Asanuma
Yoshinori Yamada
Yuko Kitagawa
Publication date
01-08-2011
Publisher
Springer Japan
Published in
International Journal of Clinical Oncology / Issue 4/2011
Print ISSN: 1341-9625
Electronic ISSN: 1437-7772
DOI
https://doi.org/10.1007/s10147-011-0185-7

Other articles of this Issue 4/2011

International Journal of Clinical Oncology 4/2011 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine